Application of intraoperative fluorescence imaging with Indocyanine Green for sinonasal tumor

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2500107949

Enrollment

Unknown

Registered

2025-08-21

Start date

2023-03-20

Completion date

Unknown

Last updated

2025-08-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sinonasal tumor

Interventions

Gold Standard:Pathological diagnosis

Index test:Index: Tumor to background ratio, Fluorescence Optical Imaging Equipment: NIR-II fluorescence imaging system with an InGaAs SWIR camera (NIRvana 640, Teledyne Princeton Instruments, USA). A

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Tumor resection can be performed after clinical evaluation, age >=18 years

Exclusion criteria

Exclusion criteria: Severe allergy to ICG or iodine, unstable systemic disease, suffering from human immune defense virus or liver disease, pregnancy or lactation, participation in other clinical trials within the past 30 days

Design outcomes

Primary

Measure	Time frame
tumor-background ratio;	—

Countries

China

Contacts

Public ContactLei Chen

Chinese PLA General Hospital

chen301@aliyun.com+86 135 1103 8301

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026